We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$419M
AUM Growth
-$93.5M
Cap. Flow
-$140M
Cap. Flow %
-33.49%
Top 10 Hldgs %
52.05%
Holding
63
New
14
Increased
15
Reduced
10
Closed
20

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$99.3M
2
UNH icon
UnitedHealth
UNH
+$17.6M
3
TMO icon
Thermo Fisher Scientific
TMO
+$8.23M
4
BDX icon
Becton Dickinson
BDX
+$6.29M
5
HCA icon
HCA Healthcare
HCA
+$6.11M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$13.5M
2
UHS icon
Universal Health Services
UHS
+$11.4M
3
ZBH icon
Zimmer Biomet
ZBH
+$9.65M
4
WAT icon
Waters Corp
WAT
+$7.83M
5
BIIB icon
Biogen
BIIB
+$6.92M

Sector Composition

Rank Sector Weight
1 Healthcare 68.68%
2 Energy 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHS icon
1
PUT
Universal Health Services
UHS
$10.5B
$85.8M 20.51%
+2,000
New +$303K
WAT icon
2
PUT
Waters Corp
WAT
$39.9B
$42.9M 10.25%
+1,000
New +$392K
HCA icon
3
HCA Healthcare
HCA
$89.5B
$13.3M 3.19%
55,000
+25,000
+83% +$6.11M
SEM
4
DELISTED
Select Medical
SEM
$13.3M 3.17%
371,200
+278,400
+300% +$5.53M
JNJ icon
5
Johnson & Johnson
JNJ
$625B
$11.3M 2.7%
70,000
+15,000
+27% +$2.56M
THC icon
6
Tenet Healthcare
THC
$21.1B
$11.1M 2.64%
80,000
-70,000
-47% -$4.97M
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
$10.3M 2.46%
39,000
+19,000
+95% +$2.96M
UNH icon
8
UnitedHealth
UNH
$370B
$10.2M 2.45%
70,000
+42,500
+155% +$17.6M
MDT icon
9
Medtronic
MDT
$112B
$10M 2.4%
80,000
– –
BSX icon
10
Boston Scientific
BSX
$71.5B
$9.55M 2.28%
220,000
+30,000
+16% +$1.33M
BAX icon
11
Baxter International
BAX
$14.2B
$9.25M 2.21%
115,000
+45,000
+64% +$3.56M
DHR icon
12
Danaher
DHR
$144B
$9.13M 2.18%
33,840
– –
MCK icon
13
McKesson
MCK
$101B
$8.97M 2.14%
45,000
+5,000
+13% +$1,000K
AVTR icon
14
Avantor
AVTR
$9.19B
$8.59M 2.05%
210,000
-40,000
-16% -$1.56M
SNN icon
15
Smith & Nephew
SNN
$12.6B
$8.57M 2.05%
+15,000
New +$591K
IQV icon
16
IQVIA
IQV
$39.3B
$8.38M 2%
35,000
– –
ABT icon
17
Abbott
ABT
$187B
$8.27M 1.98%
70,000
+20,000
+40% +$2.46M
CRL icon
18
Charles River Laboratories
CRL
$12.8B
$8.25M 1.97%
20,000
-5,000
-20% -$2.08M
CTLT
19
DELISTED
CATALENT, INC.
CTLT
$8.1M 1.94%
60,900
-9,100
-13% -$1.14M
LLY icon
20
Eli Lilly
LLY
$1.06T
$8.09M 1.93%
35,000
-5,000
-13% -$1.23M
MRK icon
21
Merck
MRK
$318B
$7.51M 1.79%
100,000
+40,000
+67% +$3.04M
EHC icon
22
Encompass Health
EHC
$12.4B
$7.5M 1.79%
125,700
+37,710
+43% +$2.37M
GMED icon
23
Globus Medical
GMED
$11.2B
$7.28M 1.74%
95,000
+40,000
+73% +$3.21M
LH icon
24
Labcorp
LH
$25.9B
$7.04M 1.68%
29,100
– –
COR icon
25
Cencora
COR
$61.2B
$6.87M 1.64%
57,500
+7,500
+15% +$901K
1
2 3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q3 2021 Portfolio in Review

As of Q3 2021, Sivik Global Healthcare held 63 positions worth $419M, down 18% from $512M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sivik Global Healthcare withdrew a net $140M in Q3 2021, closing 20 positions and reducing 10 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 55% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Regeneron Pharmaceuticals worth $5.79M.

  • Sivik Global Healthcare's largest Q3 2021 buy was Regeneron Pharmaceuticals: 160,000 shares worth $5.79M.
  • Sivik Global Healthcare added most to UnitedHealth in Q3 2021, an estimated $17.6M increase.
  • Sivik Global Healthcare's biggest Q3 2021 reduction was Humana, cutting an estimated $5.31M.
  • Sivik Global Healthcare fully exited State Street SPDR S&P Biotech ETF in Q3 2021, selling an estimated $13.5M.
  • Sivik Global Healthcare's ten largest holdings make up 52% of its $419M portfolio in Q3 2021.
  • Sivik Global Healthcare opened 14 new positions and closed 20 in Q3 2021.
  • Sivik Global Healthcare's portfolio value fell 18% quarter-over-quarter to $419M.

Based on Sivik Global Healthcare's 13F filing for Q3 2021, filed 12 Nov 2021.